US2011172170A1PendingUtilityA1

Interferon-like protein zcyto21

62
Assignee: ZYMOGENETICS INCPriority: Jun 30, 2000Filed: Mar 2, 2011Published: Jul 14, 2011
Est. expiryJun 30, 2020(expired)· nominal 20-yr term from priority
Inventors:Paul O. SheppardScott R. PresnellBrian A. FoxTeresa GilbertBetty A. HaldemanFrancis J. Grant
A61P 31/12C07K 14/52A61P 25/28C07K 14/47C07K 2319/00
62
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates to polynucleotide and polypeptide molecules for Zcyto21, an interferon-like protein, which is most closely related to interferon-α at the amino acid sequence level. The present invention also includes antibodies to the Zcyto21 polypeptides, and methods of using the polynucleotides and polypeptides.

Claims

exact text as granted — not AI-modified
1 . A method of treating a patient having multiple sclerosis comprising administering to the patient an effective amount of a polypeptide comprising an amino acid sequence having at least 95% sequence identity to amino acid residues 20-200 of SEQ ID NO:2. 
     
     
         2 . The method of  claim 1 , wherein the polypeptide comprises amino acid residues 20-200 of SEQ ID NO:2. 
     
     
         3 . The method of  claim 1 , wherein the polypeptide is pegylated.

Join the waitlist — get patent alerts

Track US2011172170A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.